Search the Newsreel

iRhythm Holdings Announces Second Quarter 2026 Financial Results

iRhythm SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2026. Second …

iRhythm earnings up next: Narrowing losses in focus tonight

iRhythm Technologies Inc. is scheduled to report second-quarter earnings, with analysts expecting a narrower loss of 5 cents per share and revenue of $219.3 million, indicating substantial improvement from the previous quarter. Investors will be focused on the company's ability to maintain rapid growth …

Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of iRhythm Technologies, Inc. Common Stock

Bernstein Litowitz Berger & Grossmann LLP announced a proposed class action settlement for purchasers of iRhythm Technologies, Inc. common stock. The $45,000,000 cash settlement aims to resolve claims alleging materially false and misleading statements regarding iRhythm's Zio AT heart monitoring device between July 25, …

iRhythm Technologies (NASDAQ:IRTC) Issues Quarterly Earnings Results

iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

iRhythm Technologies $45M Securities Class Action Settlement

iRhythm Technologies and its CEO have agreed to a $45 million securities class action settlement. Investors who purchased the company's common stock between July 25, 2022, and August 9, 2024, may be eligible to claim a cash payment. The lawsuit alleged false and misleading …

iRhythm Technologies Inc (IRTC) Institutional Confidence

The article provides an analysis of iRhythm Technologies Inc's (IRTC) institutional confidence, noting its current score of 10.00, which ranks 1st in its industry. It details that the institutional shareholding proportion is 107.08%, with a slight decrease quarter-over-quarter. The largest institutional shareholder is Steven …

Precision Trading with Irhythm Technologies Inc. (IRTC) Risk Zones

This article provides a detailed analysis of Irhythm Technologies Inc. (IRTC) with a focus on risk zones for precision trading. It highlights a potential negative sentiment shift, weak broader alignment, and an exceptional short setup with a 55.8:1 risk-reward ratio targeting a 16.0% downside. …

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (IRTC) breached their fiduciary duties to shareholders. The firm encourages long-term iRhythm shareholders to contact them to discuss potential legal rights and options, including corporate …

iRhythm Holdings (IRTC) Could Be 34% Undervalued Following Its Recent Rebound

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (IRTC) on behalf of investors who purchased securities before January 11, 2022, and still hold them. The investigation aims to determine if iRhythm and its officers engaged in corporate wrongdoing. Shareholders …

Law firm investigates iRhythm officers over alleged stock price inflation via product misrepresentation

Kuehn Law, PLLC is investigating officers and directors of iRhythm Technologies for allegedly breaching fiduciary duties by misrepresenting their Zio AT monitor. The firm claims insiders falsely promoted the product's market potential, leading to artificially inflated stock prices. Investors who purchased shares before November …

IRTC|iRhythm Technologies Inc|Price:112.260|Chg%:+3.060

This article provides a comprehensive stock analysis of iRhythm Technologies Inc (IRTC), highlighting its strong fundamentals, high growth potential, and fair valuation. The company's stock is rated a "Strong Buy" by multiple analysts with a target price of $178.00, indicating a significant upside. Key …

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (IRTC) for alleged corporate wrongdoing. The firm encourages shareholders who purchased iRhythm securities before January 11, 2022, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates …

iRhythm Technologies Inc (IRTC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for iRhythm Technologies Inc (IRTC). It notes that no dividends have been distributed by IRTC over the past five years. The page displays the current stock price, market cap, and links to various …

iRhythm Technologies Inc (IRTC) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for iRhythm Technologies Inc (IRTC), highlighting its current earnings forecast score, average price target, and analyst ratings. It indicates that 14 analysts currently rate IRTC as a "Strong Buy" with an average price target of $220.00. The company's …

Study Data Show Short-Term Holter Monitoring Misses AF Recurrence Post-Ablation in Pregnancy

New real-world study data from iRhythm Holdings Inc. indicate that short-term Holter monitoring often misses atrial fibrillation (AF) recurrence post-ablation and other arrhythmias in pregnant patients. The findings, presented at HRS 2026, suggest a shift towards continuous 14-day monitoring with devices like iRhythm's Zio …

IRTC|iRhythm Technologies Inc|Price:108.010|Chg%:+0.340

This article provides an in-depth analysis of iRhythm Technologies Inc. (IRTC), highlighting its relatively healthy fundamentals, high growth potential, and "Strong Buy" analyst rating with a target price of $178.00. Despite recent stock market underperformance, the company's valuation is considered fair within its industry, …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by iRhythm Technologies, Inc. (IRTC) and its officers/directors. Investors who purchased iRhythm securities before January 11, 2022, and still hold them, are encouraged to participate in the investigation by visiting the …

Technical Reactions to IRTC Trends in Macro Strategies

This article provides a technical analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), highlighting near-term weak sentiment that may lead to a resumption of long-term weakness. It identifies a significant risk-reward short setup and offers three distinct AI-generated trading strategies with specific entry, target, and …

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX)

This article highlights recent bullish analyst ratings for three healthcare companies: Irhythm Technologies (IRTC), Merck & Company (MRK), and Viking Therapeutics (VKTX). Analysts from BTIG, Scotiabank, and Canaccord Genuity reiterated Buy ratings, providing price targets and noting potential upsides based on current stock levels. …

Needham Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $255

Needham has reiterated its Buy rating for iRhythm Technologies (IRTC.US) and maintained a target price of $255. This continuation of a positive outlook suggests the firm sees sustained value or growth potential in the company.

IRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

iRhythm Holdings, Inc. announced it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss these results, with a live and archived …

Truist Adjusts Price Target on iRhythm Technologies to $160 From $174, Maintains Buy Rating

Truist has lowered its price target for iRhythm Technologies (IRTC) to $160 from $174, while reiterating a Buy rating on the stock. iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring services. The company recently increased its earnings guidance for the …

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by iRhythm Technologies, Inc. (NASDAQ:IRTC). The law firm encourages shareholders who purchased iRhythm securities before January 11, 2022, and still hold them, to contact them to assist with the investigation. The …

iRhythm’s Q2 Results Call Will Be Live After Aug. 6 Close

Does iRhythm (IRTC) Balancing a Revenue Beat With In-Line Guidance Recast Its AI Cardiac Story?

IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised

iRhythm (IRTC) Q1 2026 Earnings Transcript

iRhythm (IRTC) Reports Q1: Everything You Need To Know Ahead Of Earnings

iRhythm (IRTC): Buy, Sell, or Hold Post Q4 Earnings?

iRhythm Technologies Reports Strong Preliminary Q4 2025 Results and 2026 Revenue Guidance at J.P. Morgan Healthcare Conference